Na Liang
Hengyang, 421002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Mitochondria-centered signalling in pulmonary hypertension: From metabolic reprogramming to vascular remodeling and right ventricular failure.
Journal: Cellular signalling
Published: July 17, 2026
The CCL2 network in pulmonary hypertension: Potential therapeutic targets.
Journal: Cellular signalling
Published: March 31, 2026
The role of histone modifications in pulmonary hypertension: From mechanisms to therapeutic targets.
The role of histone modifications in pulmonary hypertension: From mechanisms to therapeutic targets.
Journal: Vascular pharmacology
Published: April 29, 2025
Role of inflammation in endothelial responses in Pulmonary Hypertension.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 09, 2025
Histone lactylation-derived prelamin A accelerates pulmonary arterial smooth muscle cells senescence in hypoxia-induced pulmonary hypertension rats.
Journal: International immunopharmacology
Published: February 08, 2025
Effectiveness and safety of remimazolam combined with alfentanil in hysteroscopic examination: A prospective, randomized, single-blind trial.
Journal: Medicine
Published: April 12, 2024
Upregulation of eIF2α by m6A modification accelerates the proliferation of pulmonary artery smooth muscle cells in MCT-induced pulmonary arterial hypertension rats.
Journal: Journal of cardiovascular translational research
Published: June 28, 2023
Targeting Vascular Smooth Muscle Cell Senescence: A Novel Strategy for Vascular Diseases.
Journal: Journal of cardiovascular translational research
Published: November 28, 2022
Opioids in cancer: The κ‑opioid receptor (Review).
Journal: Molecular medicine reports
Published: August 17, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026